CAS 103177-37-3

Benzamide, N-[4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-

Description:

Benzamide, N-[4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-, identified by its CAS number 103177-37-3, is a synthetic organic compound characterized by its complex molecular structure, which includes a benzamide moiety and a benzopyran derivative. This compound features a tetrazole ring, contributing to its potential biological activity, particularly in medicinal chemistry. The presence of the phenylbutoxy group enhances its lipophilicity, which may influence its pharmacokinetic properties. Typically, compounds of this nature are investigated for their potential therapeutic applications, including anti-inflammatory, antimicrobial, or anticancer activities. The molecular interactions of this compound can be influenced by its functional groups, which may engage in hydrogen bonding or π-π stacking interactions. As with many synthetic organic compounds, its stability, solubility, and reactivity can vary based on environmental conditions and the presence of other chemical species. Further studies, including in vitro and in vivo assays, are essential to fully elucidate its biological properties and potential applications in drug development.

Formula: C₂₇H₂₃N₅O₄

InChI: InChI=1/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32)

InChI key: InChIKey=NBQKINXMPLXUET-UHFFFAOYSA-N

SMILES: N(C(=O)C1=CC=C(OCCCCC2=CC=CC=C2)C=C1)C3=C4C(C(=O)C=C(O4)C=5NN=NN5)=CC=C3

Synonyms:

• PLST
• N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide
• Benzamide, N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-
• RS 411
• N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide
• Pranlukast hemihydrate crude
• Benzamide, N-[4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)-
• ONO 1078
• N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide
• 4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran
• N-[4-Oxo-2-(2H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide
• hemihydrate
• ONO-RS-411-01
• rs411
• n-(4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzam
• N-{4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide, ONO-1078, ONO-RS-411, Onon,
• ONO-RS-411
• PRANLUKAST
• 4-oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4h-1-benzopyranh
• ono1078
• emihydrate

Pranlukast

CAS: 103177-37-3

Formula: C₂₇H₂₃N₅O₄

Purity: >98.0%(HPLC)

Color and Shape: White to Almost white powder to crystal

Molecular weight: 481.51

Ref: 3B-P2115

Pranlukast

CAS: 103177-37-3

Formula: C₂₇H₂₃N₅O₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 481.5026

Ref: IN-DA008R1P

Pranlukast

CAS: 103177-37-3

Pranlukast (ONO-1078) is a cysteinyl leukotriene receptor-1 antagonist.

Formula: C₂₇H₂₃N₅O₄

Purity: 99.41%

Color and Shape: Off-White Solid

Molecular weight: 481.5

Ref: TM-T0694

Pranlukast

CAS: 103177-37-3

Pranlukast

Purity: ≥98%

Molecular weight: 481.5g/mol

Ref: 54-BUP11884

Pranlukast

CAS: 103177-37-3

Formula: C₂₇H₂₃N₅O₄

Color and Shape: White To Off-White Solid

Molecular weight: 481.51

Ref: 4Z-P-401

Pranlukast-d4

CAS: 103177-37-3

Formula: C₂₇H₁₉D₄N₅O₄

Color and Shape: Pale Yellow Solid

Molecular weight: 485.54

Ref: 4Z-P-402

4-Oxo-8-(4-(4-Phenylbutoxy)Benzoylamino)-2-(Tetrazol-5-yl)-4H-1-Benzopyran

CAS: 103177-37-3

4-Oxo-8-(4-(4-Phenylbutoxy)Benzoylamino)-2-(Tetrazol-5-yl)-4H-1-Benzopyran

Purity: 99%

Molecular weight: 481.50g/mol

Ref: 54-OR1011647

Pranlukast

Controlled Product

CAS: 103177-37-3

Formula: C₂₇H₂₃N₅O₄

Color and Shape: Neat

Molecular weight: 481.50

Ref: TR-P701100

Pranlukast

CAS: 103177-37-3

Cysteinyl leukotriene receptor antagonist

Formula: C₂₇H₂₃N₅O₄

Purity: Min. 95%

Molecular weight: 481.5 g/mol

Ref: 3D-FP27120